Perceptions and Challenges Experienced by African Physicians When Prescribing Methotrexate for Rheumatic Disease: An Exploratory Study
ACR Open Rheumatology2021Vol. 3(8), pp. 522–530
Citations Over TimeTop 24% of 2021 papers
Carol Hitchon, Girsh M. Mody, Candace H. Feldman, Yan Kwan Lau, Steven Shi, Michele Meltzer, Rosie Scuccimarri, Michael E. Weinblatt, Inés Colmegna
Abstract
The challenges of treating rheumatic disease in African countries include unreliable drug availability and cost, limited subspecialists, and patient beliefs. Adapting recommendations for MTX use in the context of prevalent endemic infections; ensuring safe but feasible MTX monitoring strategies, enhanced access to stable drug supply, and specialized rheumatology care; and improving patient education are key to reducing the burden of rheumatic diseases in L-HDI countries.
Related Papers
- Clinical observation of mifepristone in combination with methotrexate for the medical treatment of ectopic pregnancy(2002)
- 융모성상피암에 있어서의 Methotrexate 포화검사의 의의(1991)
- → METHOTREXATE-Reply(1969)
- Efficacy And Safety Of Methotrexate In Psoriasis A Reappraisal(2000)